Carlos A Castro-Callirgos

A Randomized Trial of Lipid Metabolism Modulation with Fenofibrate for Acute Coronavirus Disease 2019

P. López-Jaramillo, C. Vlachopoulos, H. Milionis, 2022, Research square.

A randomized clinical trial of lipid metabolism modulation with fenofibrate for acute coronavirus disease 2019

P. López-Jaramillo, C. Vlachopoulos, M. Putt, 2022, Nature Metabolism.

Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial

T. Chang, A. Barbagelata, J. Chittams, 2021, The Lancet Respiratory Medicine.

Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol

T. Chang, A. Barbagelata, M. Harhay, 2020, Journal of clinical hypertension.